Softwr

Healthcare · head to head

Annalise.ai vs Oracle Clinical One

Annalise.ai logo

Annalise.ai

Healthcare

Multi-finding chest X-ray and head CT triage AI with FDA clearance on named findings, not on the whole model

From
On request
Rated
-
Full reviewWebsite
Oracle Clinical One logo

Oracle Clinical One

Healthcare

Unified clinical trial data collection and randomisation on one Oracle Life Sciences platform

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Annalise.ai the United States cleared indication covers roughly ten findings for triage and notification, far fewer than the model reports, so a buyer who evaluates the full multi-finding output and then contracts in the United States gets a much narrower cleared use.; Oracle Clinical One nothing about the commercial terms is published, so cost, implementation length and validation scope all emerge inside an enterprise sales process, and comparison shopping requires running parallel procurements.
  • They diverge on capability: Annalise.ai covers Annalise Enterprise CXR, Oracle Clinical One covers Unified platform.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Annalise.ai and Oracle Clinical One actually diverge.

Attributes where Annalise.ai and Oracle Clinical One differ
AttributeAnnalise.aiOracle Clinical One
PlatformsWeb, Cloud, On-premiseWeb, iOS, Android

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Annalise.ai

  • Annalise Enterprise CXR
  • Annalise Enterprise CTB
  • Triage and notification
  • Worklist reprioritisation
  • Localisation overlays
  • Confidence output
  • PACS-native deployment
  • On-premise or cloud inference

Only in Oracle Clinical One

  • Unified platform
  • Data collection
  • Randomisation and supplies
  • No-code study build
  • Regulatory compliance
  • Mid-study changes
  • Integrations
  • Cloud delivery

What people use each for

The jobs each tool is most often brought in to do.

Annalise.ai

  • An emergency department wanting pneumothorax and intracranial haemorrhage pushed to the front of the reading queue overnight when cover is thinnestnot Oracle Clinical One
  • A teleradiology provider covering many small hospitals that needs consistent triage before a human readsnot Oracle Clinical One
  • A screening programme in Europe where the broader CE marked decision support indication, rather than the narrow United States triage clearance, is what is being deployednot Oracle Clinical One
  • A radiology department building an AI governance programme that wants one vendor covering both chest radiograph and head CT rather than contracting two separate algorithm suppliersnot Oracle Clinical One

Oracle Clinical One

  • A sponsor running a complex Phase III where randomisation errors between separate EDC and RTSM vendors have already cost timenot Annalise.ai
  • A pharmaceutical company already on Oracle Clinical or InForm that needs a supported migration path off end-of-life systemsnot Annalise.ai
  • A trial with adaptive randomisation and drug supply forecasting that would otherwise need custom programming per amendmentnot Annalise.ai
  • A CRO standardising study build across many sponsor programmes on one validated platformnot Annalise.ai

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Annalise.ai

  • The United States cleared indication covers roughly ten findings for triage and notification, far fewer than the model reports, so a buyer who evaluates the full multi-finding output and then contracts in the United States gets a much narrower cleared use.
  • Triage AI reprioritises a worklist but does not change clinical decisions on its own, so departments that do not redesign how urgent studies are picked up see no measurable improvement in time to treatment.
  • Published validation is largely reader study evidence on detection of individual findings; prospective evidence of shorter time to treatment in routine emergency care is thin.
  • The Annalise brand is being migrated under the Harrison.ai name for the critical care offering, which creates ambiguity in multi-year contracts about what product name is actually being supported.
  • A high finding count raises the alert burden, and departments report that low prevalence findings generate false positives that erode radiologist trust unless the alerting thresholds are tuned locally.

Oracle Clinical One

  • Nothing about the commercial terms is published, so cost, implementation length and validation scope all emerge inside an enterprise sales process, and comparison shopping requires running parallel procurements.
  • Placing data collection and randomisation with a single vendor concentrates risk: an outage or a defect affects both of the systems your sites cannot work without.
  • Mid-study amendments are routine in trials but flow through the vendor change control process, and change orders are where the real cost of an Oracle trial platform accumulates after signature.
  • Implementation and study build require specialist staff or Oracle services, so the practical time from contract to first patient in is measured in months, not weeks.
  • It is aimed squarely at sponsors and CROs with established trial operations, and a small biotech running its first study will find the platform, the contracting and the validation burden heavier than its team can absorb.

Pricing, plan by plan

Annalise.ai

On request
  • Annalise Enterprise$undefined/year
    • Priced per study analysed or as an annual volume subscription
    • CXR and CTB licensed separately
    • Cleared finding set differs by market, which changes what you are buying

Oracle Clinical One

On request
  • Clinical One Data Collection$undefined/year
    • Pricing only through Oracle sales
    • Priced against study count, sites and subjects
    • Study build and configuration services quoted separately
  • Clinical One Randomization and Supplies Management$undefined/year
    • Quoted alongside or independently of Data Collection
    • Randomisation strategy configuration included in the service
    • Supply forecasting and kit management

Which should you pick?

Choose Annalise.ai if

  • You need annalise enterprise cxr.
  • You work on Web, Cloud, On-premise.
  • You also want annalise enterprise ctb.
Annalise.ai review

Choose Oracle Clinical One if

  • You need unified platform.
  • You work on Web, iOS, Android.
  • You also want data collection.
Oracle Clinical One review

Questions people ask

Is Annalise.ai or Oracle Clinical One better?
Neither clearly leads. Annalise.ai starts at On request and Oracle Clinical One at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Annalise.ai or Oracle Clinical One?
Annalise.ai starts at On request and Oracle Clinical One at On request.
Does Annalise.ai or Oracle Clinical One run on more platforms?
Annalise.ai runs on Web, Cloud, On-premise. Oracle Clinical One runs on Web, iOS, Android.
What is Annalise.ai best used for?
Annalise.ai is most often used for an emergency department wanting pneumothorax and intracranial haemorrhage pushed to the front of the reading queue overnight when cover is thinnest, a teleradiology provider covering many small hospitals that needs consistent triage before a human reads, a screening programme in europe where the broader ce marked decision support indication, rather than the narrow united states triage clearance, is what is being deployed, a radiology department building an ai governance programme that wants one vendor covering both chest radiograph and head ct rather than contracting two separate algorithm suppliers. Of those, an emergency department wanting pneumothorax and intracranial haemorrhage pushed to the front of the reading queue overnight when cover is thinnest and a teleradiology provider covering many small hospitals that needs consistent triage before a human reads are not what Oracle Clinical One is typically brought in for.
What can Annalise.ai do that Oracle Clinical One cannot?
Annalise.ai covers Annalise Enterprise CXR, Annalise Enterprise CTB, Triage and notification, Worklist reprioritisation. Oracle Clinical One covers Unified platform, Data collection, Randomisation and supplies, No-code study build.

Answered from the vendors’ own pages

Annalise.ai: How many findings are FDA cleared?

Around ten across chest X-ray and head CT, for triage and notification only. The model reports far more findings than that; the rest are not cleared in the United States.

Oracle Clinical One: What replaced Oracle Clinical and InForm?

Clinical One is the current Oracle Life Sciences platform, and sponsors on the older Oracle Clinical and InForm products are the primary migration audience.

Annalise.ai: Is the European position different?

Yes. CE marking under the medical device regulation covers a broader decision support indication than the United States triage and notification clearances, so the same software is a different regulatory product depending on where you deploy it.

Oracle Clinical One: Can I buy randomisation without data collection?

Yes. Clinical One Randomization and Supplies Management can integrate with a third-party EDC if you want to keep an incumbent capture system.

Annalise.ai: Does it diagnose?

No. In the United States it is a triage and notification device: it flags studies for earlier review, and the radiologist makes the diagnosis.

Oracle Clinical One: Is pricing published?

No. Every element, including licence, study build, implementation and validation, comes through Oracle sales.

Annalise.ai: Is Annalise.ai becoming Harrison.ai?

The critical care offering is now marketed under the Harrison.ai name. Ask the vendor to name the contracted product explicitly before signing a multi-year deal.

Oracle Clinical One: Is it validated for regulated trials?

It is delivered as a validated cloud service with GxP documentation and Part 11 aligned audit trails, but sponsor-level validation of your own configuration remains your responsibility.

Share

Related pages

More on Annalise.ai

More on Oracle Clinical One

Keep looking

Other head to heads